glass tissue grinder (Kontes Glass)
86
Structured Review
Kontes Glass
glass tissue grinder
Glass Tissue Grinder, supplied by Kontes Glass, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glass+tissue+grinder/grinder+tissue/10__1096_slash_fj__202504935r-115-24-27
Average 86 stars, based on 1 article reviews
Glass Tissue Grinder, supplied by Kontes Glass, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glass+tissue+grinder/grinder+tissue/10__1096_slash_fj__202504935r-115-24-27
Average 86 stars, based on 1 article reviews
glass tissue grinder - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Centrifugation:Article Title: Structural insights into the regulation of RyR1 by S100A1. Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders Article Snippet: .. After centrifugation for 30 min at 36,000× g , the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation Article Snippet: .. Membrane fractions were pelleted by centrifugation at 36,000 g for 30 minutes and solubilized in buffer B (10 mM HEPES, pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, and 1 protease inhibitor tablet [Pierce]) using a Article Title: Structural insights into the regulation of RyR1 by S100A1 Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. Article Snippet: .. After centrifugation for 30 min at 36,000×g, the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Membrane:Article Title: Structural insights into the regulation of RyR1 by S100A1. Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders Article Snippet: .. After centrifugation for 30 min at 36,000× g , the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation Article Snippet: .. Membrane fractions were pelleted by centrifugation at 36,000 g for 30 minutes and solubilized in buffer B (10 mM HEPES, pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, and 1 protease inhibitor tablet [Pierce]) using a Article Title: Structural insights into the regulation of RyR1 by S100A1 Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. Article Snippet: .. After centrifugation for 30 min at 36,000×g, the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Protease Inhibitor:Article Title: Structural insights into the regulation of RyR1 by S100A1. Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders Article Snippet: .. After centrifugation for 30 min at 36,000× g , the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation Article Snippet: .. Membrane fractions were pelleted by centrifugation at 36,000 g for 30 minutes and solubilized in buffer B (10 mM HEPES, pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, and 1 protease inhibitor tablet [Pierce]) using a Article Title: Structural insights into the regulation of RyR1 by S100A1 Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. Article Snippet: .. After centrifugation for 30 min at 36,000×g, the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Homogenization:Article Title: Structural insights into the regulation of RyR1 by S100A1. Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders Article Snippet: .. After centrifugation for 30 min at 36,000× g , the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation Article Snippet: .. Membrane fractions were pelleted by centrifugation at 36,000 g for 30 minutes and solubilized in buffer B (10 mM HEPES, pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, and 1 protease inhibitor tablet [Pierce]) using a Article Title: Structural insights into the regulation of RyR1 by S100A1 Article Snippet: .. After centrifugation for 30 min at 36,000 g, the pelleted membrane fraction was solubilized in buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Article Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. Article Snippet: .. After centrifugation for 30 min at 36,000×g, the pelleted membrane fraction was solubilized in 8 mL of buffer B [10 mM HEPES pH 7.4, 0.8 M NaCl, 1% CHAPS, 0.1% phosphatidylcholine, 1 mM EGTA, 2 mM DTT, 0.5 mM AEBSF, 1 mM benzamidine hydrochloride, one protease inhibitor tablet (Pierce)] followed by homogenization using a Saline:Article Title: Dual Knockout Models of the Spatially and Functionally Conserved
<i>rgra</i>
and
<i>rgrb</i>
Zebrafish Genes Reveal the Requirement of
<scp>RGR</scp>
for the Integrity of Cone‐Mediated Photopic Vision, the Photopic Visual Cycle and Bruch's Membrane Morphology Article Snippet: .. The individual biological replicates were stored at −80°C and thawed on ice before being homogenized in 500 μL phosphate- buffered saline (PBS) using a |